Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "An Essential Overview of the Pharmaceutical and Biotech Industries (Sept 28, 2026)" has been added to ResearchAndMarkets.com's offering. This...
-
Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Interpersonal Project Management Skills for the Life Sciences Industries Training Course (July 16th - July 17th, 2026)" training has been added to ...
-
PiNACLE pivotal clinical trial evaluating ronde-cel in patients with LBCL in third- or later-line setting on track to report additional data in second half of 2026, with pivotal data expected mid-2027...
-
Q1 updates: Q1 2026 total revenues of $90.2M, +15% vs. Q1 2025Built out launch infrastructure and aligned field-based teams for upcoming launchesSettlement of senior convertible notes of $36.3M ...
-
Austin, TX, USA, May 06, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “RNA Targeting Small Molecule Drug Discovery Market Size, Trends and Insights By...
-
CARBOGEN AMCIS Shanghai Site achieves successful outcome in Unannounced NMPA GMP Inspection
-
SAN FRANCISCO, May 06, 2026 (GLOBE NEWSWIRE) -- Immusoft of CA, a clinical-stage biotechnology company pioneering engineered B cell therapies, today announced that Scott McIvor, Chief Development...
-
- Global 4WARD Phase 3 Chronic Neutropenia Trial On Track to Complete Enrollment by the end of Q3 2026 - - European Commission Approval of XOLREMDI® (Mavorixafor) Provides the First and Only...
-
Fristads aide ses clients à réduire leur impact climatique – des économies de CO₂e équivalentes à 1 850 vols aller-retour entre Helsinki et Munich en 2025.
-
Fristads hjelper kunder med å redusere klimabelastningen – CO₂e-besparelser tilsvarende 1 850 tur-retur-flyreiser mellom Helsinki og München i 2025.